ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04080	Neuroactive ligand-receptor interaction	115/830	423/7206	5.02569266196e-20
ko04020	Calcium signaling pathway	72/830	265/7206	9.05572069931e-13
ko04724	Glutamatergic synapse	49/830	152/7206	5.10394802522e-12
ko04713	Circadian entrainment	43/830	136/7206	2.14190418193e-10
ko04024	cAMP signaling pathway	66/830	279/7206	4.91438220787e-09
ko05032	Morphine addiction	35/830	110/7206	8.75964028293e-09
ko05033	Nicotine addiction	23/830	56/7206	1.45990651952e-08
ko04921	Oxytocin signaling pathway	53/830	209/7206	1.5014590266e-08
ko04022	cGMP-PKG signaling pathway	54/830	216/7206	2.55622746525e-08
ko04728	Dopaminergic synapse	48/830	185/7206	3.1901564972e-08
ko04911	Insulin secretion	35/830	117/7206	5.13950274063e-08
ko04727	GABAergic synapse	33/830	110/7206	1.14991097748e-07
ko04725	Cholinergic synapse	42/830	160/7206	2.08124832831e-07
ko04970	Salivary secretion	29/830	95/7206	4.48975204214e-07
ko04261	Adrenergic signaling in cardiomyocytes	48/830	205/7206	1.06954077497e-06
ko04720	Long-term potentiation	29/830	99/7206	1.16930338946e-06
ko04721	Synaptic vesicle cycle	25/830	80/7206	1.72339876271e-06
ko05031	Amphetamine addiction	27/830	91/7206	2.07388216225e-06
ko04070	Phosphatidylinositol signaling system	31/830	112/7206	2.93833657589e-06
ko04730	Long-term depression	24/830	78/7206	3.76662103728e-06
ko03010	Ribosome	1/830	129/7206	4.29537886686e-06
ko03040	Spliceosome	2/830	145/7206	5.10938904305e-06
ko04726	Serotonergic synapse	34/830	137/7206	9.81279269125e-06
ko04723	Retrograde endocannabinoid signaling	40/830	175/7206	1.82620569102e-05
ko03013	RNA transport	4/830	166/7206	2.1953636162e-05
ko05322	Systemic lupus erythematosus	3/830	151/7206	2.48407532284e-05
ko04925	Aldosterone synthesis and secretion	27/830	105/7206	4.03493153037e-05
ko04745	Phototransduction - fly	14/830	38/7206	4.38729125911e-05
ko04710	Circadian rhythm	15/830	43/7206	4.94358337337e-05
ko04922	Glucagon signaling pathway	31/830	128/7206	5.8919404514e-05
ko04971	Gastric acid secretion	25/830	98/7206	8.97149766057e-05
ko04742	Taste transduction	18/830	61/7206	0.000112211482574
ko04514	Cell adhesion molecules (CAMs)	30/830	130/7206	0.000144969757751
ko04072	Phospholipase D signaling pathway	41/830	197/7206	0.000151361878855
ko05168	Herpes simplex infection	7/830	182/7206	0.000359887051421
ko04010	MAPK signaling pathway	58/830	321/7206	0.000440502029252
ko05203	Viral carcinogenesis	15/830	277/7206	0.000706837780072
ko04750	Inflammatory mediator regulation of TRP channels	27/830	122/7206	0.000795007715043
ko04110	Cell cycle	5/830	145/7206	0.000871112087973
ko04014	Ras signaling pathway	50/830	279/7206	0.00147395115122
ko04270	Vascular smooth muscle contraction	31/830	154/7206	0.00191444044177
ko04972	Pancreatic secretion	24/830	111/7206	0.00227268005718
ko04626	Plant-pathogen interaction	7/830	18/7206	0.00265358651457
ko00604	Glycosphingolipid biosynthesis - ganglio series	6/830	14/7206	0.00304189230826
ko04540	Gap junction	26/830	128/7206	0.00316953162156
ko04120	Ubiquitin mediated proteolysis	6/830	138/7206	0.00450077731557
ko04360	Axon guidance	41/830	233/7206	0.00473133045201
ko04924	Renin secretion	19/830	86/7206	0.00549207342831
ko00562	Inositol phosphate metabolism	19/830	89/7206	0.00673575192265
ko04141	Protein processing in endoplasmic reticulum	10/830	184/7206	0.00675892683177
ko04966	Collecting duct acid secretion	8/830	26/7206	0.00701205716844
ko04371	Apelin signaling pathway	32/830	177/7206	0.00842031198161
ko05030	Cocaine addiction	16/830	73/7206	0.00913783553691
ko05130	Pathogenic Escherichia coli infection	2/830	77/7206	0.0104890020296
ko04612	Antigen processing and presentation	2/830	77/7206	0.0104890020296
ko04964	Proximal tubule bicarbonate reclamation	8/830	29/7206	0.0141133791183
ko04657	IL-17 signaling pathway	3/830	87/7206	0.0163133197383
ko04923	Regulation of lipolysis in adipocytes	16/830	77/7206	0.017813440236
ko00520	Amino sugar and nucleotide sugar metabolism	1/830	55/7206	0.017821369719
ko05164	Influenza A	10/830	167/7206	0.0196580307737
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	16/830	79/7206	0.0204626899932
ko04960	Aldosterone-regulated sodium reabsorption	10/830	41/7206	0.0221503161566
ko04260	Cardiac muscle contraction	19/830	98/7206	0.0238546662292
ko00010	Glycolysis / Gluconeogenesis	15/830	74/7206	0.0262144322208
ko05014	Amyotrophic lateral sclerosis (ALS)	15/830	74/7206	0.0262144322208
ko04930	Type II diabetes mellitus	12/830	54/7206	0.0284519295453
ko05110	Vibrio cholerae infection	13/830	63/7206	0.0292422064963
ko05161	Hepatitis B	11/830	173/7206	0.0295570112569
ko05224	Breast cancer	11/830	174/7206	0.0296886772003
ko04740	Olfactory transduction	16/830	80/7206	0.0320083573337
ko05230	Central carbon metabolism in cancer	16/830	81/7206	0.0330471522331
ko05169	Epstein-Barr virus infection	14/830	206/7206	0.0344627311701
ko05219	Bladder cancer	1/830	48/7206	0.0383746902563
ko04114	Oocyte meiosis	24/830	139/7206	0.0427351604016
ko04015	Rap1 signaling pathway	43/830	278/7206	0.0435406443786
ko00240	Pyrimidine metabolism	6/830	110/7206	0.0487695407031